Skip to content
1932

Q&A

Time for half-year resolutions?

If your good intentions from a few months ago haven’t led to much, take note. A psychologist tells us what we can learn from studies on willpower.

In defense of wild meat’s place at the table

Sustainable and safe consumption of wildlife is possible, and important for those who depend on it, says a conservation researcher

Psychedelic drugs and the law: What’s next?

The push to legalize magic mushrooms, MDMA, LSD and other hallucinogens is likely to heighten tensions between state and federal law, drug law expert Robert Mikos says

The growing link between microbes, mood and mental health

New research suggests that to maintain a healthy brain, we should tend our gut microbiome. The best way to do that right now is not through pills and supplements, but better food.

The remaining frontiers in fighting hepatitis C

A scientist whose work was key to identifying, studying and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist

She saw the obesity epidemic coming. Then an unexpected finding mired her in controversy.

Katherine Flegal was a scientist who found herself crunching numbers for the government, until one day her analyses set off a firestorm. What does she make of her decades as a woman in public health research?

Making microbots smart

What would it take to create a truly intelligent microbot, one that can operate independently? A roboticist describes the fascinating minutiae and the medical jobs these tiny machines could do for us.

Vaccinating the world against Covid-19

Lower-income countries haven’t gotten an equal share of lifesaving coronavirus vaccines. Older, more familiar vaccine technologies may hold the key to more equitable use, says Maria Elena Bottazzi.

To understand airborne transmission of disease, follow the flow

Viruses and bacteria travel in fluids, such as the air we breathe. Studying exhalations, toilet flushes and rain drops, with math and modeling, can sharpen the big-picture view of how to prevent infections.

Studying poverty through a child’s eyes

Research on early-life adversity should pay more attention to the perspective of children themselves

Emotions get better with age

As people grow older, they gain greater control of their feelings. How do they do that — and can they teach young whippersnappers a thing or two?

How health insurance is faring under Covid

Millions of Americans lost employer-sponsored coverage when Covid-19 disrupted their jobs. Can America come up with a better system?

Battling arsenic pollution

Arsenic-poisoned water remains a threat to public health the world over. Scientists hope to change that.

Pandemic puts all eyes on public health

Covid-19 has exposed the weak spots of the US public health system — and that presents an opportunity, says an epidemiologist, for the nation to recognize the problems and act to fix them

Making and breaking connections in the brain

The links between nerve cells, called synapses, allow us to learn and adapt, and hold clues to conditions such as autism, schizophrenia and more

Matching meals to metabolism

Genes, microbes and other factors govern how each person’s body processes nutrients. Understanding the connections could help optimize diets — and health.

The trouble with medicating mental illness

Psychotropic drugs have severely narrowed how we treat psychiatric disorders — to the detriment of patients and society as a whole. A look at the past suggests a better way forward.

Speaking of pandemics: The art and science of risk communication

Public health messages should be loud and clear, so that everyone listens and stays safe. But that’s easier said than done — especially with a case as complex as Covid-19.

America the Unhealthy: Inequality kills

Smoking, poor diet, lack of exercise? Yes, but that’s not all. A researcher tells us what really hurts US life expectancy.

The challenge of conducting clinical research during a pandemic

Drug treatments and vaccines for Covid-19 are needed fast. But developing them in mid-outbreak is logistically hard and ethically tricky. A veteran vaccine researcher explains.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error